Document Detail

Adoption and utilization of sexually transmitted infections testing in outpatient substance abuse treatment facilities serving high risk populations in the U.S.
MedLine Citation:
PMID:  20970314     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Although adoption and utilization of sexually transmitted infection (STI) testing is a cost effective public health intervention, it is inconsistently offered or referred out for by outpatient substance abuse treatment (OSAT) programs where at-risk racial/ethnic and sexual minorities receive services.
METHODS: We explored the organizational adoption and client utilization of STI testing using a nationally representative sample of OSAT facilities in the U.S. in 2005 (N=566). Data missing at random was imputed and the resulting database was analysed using multivariate Tobit and logistic regressions.
RESULTS: The analyses suggest that private non-profit facilities, which are the largest providers of OSAT treatment are less likely than public facilities to offer STI testing or to report adequate client utilization rates. Higher utilization was instead associated with professionally accredited facilities, and with facilities whose majority of clients were Latino/a, reported a history of treatment, stayed in treatment longer, or received case management.
CONCLUSION: While OSAT facilities are poised to be primary intervention points for diagnosis and treatment of STIs, only a segment of these facilities provide this preventive practice or manage to refer clients out. As such, U.S. health care policy should ensure the adoption and comprehensive utilization, particularly among high risk clients, of this cost-effective prevention strategy in OSAT admission protocols.
Erick G Guerrero; Julie A Cederbaum
Related Documents :
21133064 - Mapping student response team activities to public health competencies: are we adequate...
11033664 - Ocular risks from sunlight exposure.
12442994 - Integrating risk assessment and life cycle assessment: a case study of insulation.
20094044 - Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis.
10607854 - Bioethics, biotechnology products and humans: europe between the skilled theseus and th...
23281664 - 'going private': a qualitative comparison of medical specialists' job satisfaction in t...
Publication Detail:
Type:  Journal Article     Date:  2010-10-20
Journal Detail:
Title:  The International journal on drug policy     Volume:  22     ISSN:  1873-4758     ISO Abbreviation:  Int. J. Drug Policy     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2011-01-31     Completed Date:  2011-08-09     Revised Date:  2014-09-05    
Medline Journal Info:
Nlm Unique ID:  9014759     Medline TA:  Int J Drug Policy     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  41-8     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 Elsevier B.V. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Age Factors
Ambulatory Care Facilities / organization & administration
HIV Infections / diagnosis*,  prevention & control
Mass Screening / methods*
Risk Factors
Sex Factors
Sexual Behavior*
Sexually Transmitted Diseases / diagnosis*,  economics,  ethnology,  prevention & control
Substance Abuse Treatment Centers / organization & administration*
Substance-Related Disorders / ethnology,  rehabilitation*
Grant Support
F31 DA024564/DA/NIDA NIH HHS; F31 DA024564-02/DA/NIDA NIH HHS

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The function of porcine PPAR? and dietary fish oil effect on the expression of lipid and glucose met...
Next Document:  Integration of single-cell trapping and impedance measurement utilizing microwell electrodes.